Abstract:PURPOSE: Glioblastoma, a common malignant intracranial tumor, has the most dismal prognosis. Autophagy was reported to act as a survival-promoting mechanism in gliomas by inducing epithelial-to-mesenchymal transition (EMT). Here, we determined the critical molecules involved in autophagy-induced EMT and elucidated the possible mechanism of chemoradiotherapy resistance and tumor recurrence.EXPERIMENTAL DESIGN: We used isobaric tags for relative and absolute quantitation to identify the critical proteins and pathway mediating EMT via autophagy inducer treatment, and tested the expression of these proteins using tissue microarray of gliomas and clinical glioblastoma samples as well as tissues and cells separated from the core lesion and tumor-peripheral region. Analysis of the Cancer Genome Atlas database and 110 glioblastoma cases revealed the prognostic value of these molecules. The functional role of these critical molecules was further confirmed by in vitro experiments and intracranial xenograft in nude mice.RESULTS: Autophagy inducers significantly upregulated the expression of HERC3, which promotes ubiquitination-mediated degradation of SMAD7 in an autolysosome-dependent manner. The corresponding increase in p-SMAD2/3 level and TGFβ pathway activation finally induced EMT in cell lines and primary glioblastoma cells. Moreover, HERC3 overexpression was observed in pseudo-palisade cells surrounding tumor necrosis and in tumor-adjacent tissue; high HERC3 and low SMAD7 levels predicted poor clinical outcome in glioblastoma; xenograft of nude mice and in vitro experiments confirmed these findings.CONCLUSIONS: Together, our findings reveal the indispensable role of HERC3 in regulating canonical SMAD2/3-dependent TGFβ pathway involvement in autophagy-induced EMT, providing insights toward a better understanding of the mechanism of resistance to temozolomide and peripheral recurrence of glioblastoma.

Importance of Autophagy Regulation in Glioblastoma with Temozolomide Resistance

Targeting autophagy to sensitive glioma to temozolomide treatment

Regulation of autophagy as a therapeutic option in glioblastoma

An Interplay between Senescence, Apoptosis and Autophagy in Glioblastoma Multiforme-Role in Pathogenesis and Therapeutic Perspective

Assessing Autophagy Flux in Glioblastoma Temozolomide Resistant Cells

Abstract 7204: Therapeutic potential of targeting autophagy to overcome chemoresistance in glioblastoma

Therapeutic Potential of Autophagy in Glioblastoma Treatment With Phosphoinositide 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin Signaling Pathway Inhibitors

Targeting Off-Target Effects: Endoplasmic Reticulum Stress and Autophagy As Effective Strategies to Enhance Temozolomide Treatment

TTK Protein Kinase Promotes Temozolomide Resistance Through Inducing Autophagy in Glioblastoma.

Autophagy Machinery in Glioblastoma: the Prospect of Cell Death Crosstalk and Drug Resistance with Bioinformatics Analysis.

Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma

Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review

The Role of Autophagy in Sensitizing Malignant Glioma Cells to Radiation Therapy

Autophagy: a strategy for malignant gliomas' resistance to therapy.

Therapeutic Perspective of Temozolomide Resistance in Glioblastoma Treatment.

Interfering with mitochondrial dynamics sensitizes glioblastoma multiforme to temozolomide chemotherapy

MicroRNAs as the pivotal regulators of Temozolomide resistance in glioblastoma

Research progress of drug resistance mechanism of temozolomide in the treatment of glioblastoma

HERC3-Mediated SMAD7 Ubiquitination Degradation Promotes Autophagy-Induced EMT and Chemoresistance in Glioblastoma

Deciphering the Role of Autophagy in Treatment of Resistance Mechanisms in Glioblastoma

Autophagy Mediates Glucose Starvation-Induced Glioblastoma Cell Quiescence and Chemoresistance Through Coordinating Cell Metabolism, Cell Cycle, and Survival